SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a great threat to public health, being a causative pathogen of a deadly coronavirus disease (COVID-19). It has spread to more than 200 countries and infected millions of individuals globally. Although SARS-CoV-2 has structural/genomic s...
Main Authors: | Iqra Mehmood, Munazza Ijaz, Sajjad Ahmad, Temoor Ahmed, Amna Bari, Asma Abro, Khaled S. Allemailem, Ahmad Almatroudi, Muhammad Tahir ul Qamar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-4601/18/4/1626 |
Similar Items
-
Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance
by: Patrick J. Lenehan, et al.
Published: (2021-07-01) -
Spontaneous pneumomediastinum occurring in the SARS-COV-2 infection
by: Sylvie Kolani, et al.
Published: (2020-01-01) -
THALASSAEMIA INTERMEDIA : AN UPDATE
by: Maria Domenica Cappellini, et al.
Published: (2009-06-01) -
THALASSAEMIA INTERMEDIA : AN UPDATE
by: Ali Taher, et al.
Published: (2009-08-01) -
JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules
by: Jakub Jankowski, et al.
Published: (2021-08-01)